Innate Pharma
IPHA
#9026
Rank
NZ$0.25 B
Marketcap
NZ$2.67
Share price
-5.42%
Change (1 day)
-16.86%
Change (1 year)

Half-year Reports

Thumbnail Innate Pharma
 Half-year Report 2025-h1

Half-year Report 2025-h1

Language: English

View Half-year Report
Thumbnail Innate Pharma
 Half-year Report 2024-h1

Half-year Report 2024-h1

Language: English

View Half-year Report
Thumbnail Innate Pharma
 Half-year Report 2023-h1

Half-year Report 2023-h1

Language: English

View Half-year Report
Thumbnail Innate Pharma
 Half-year Report 2022-h1

Half-year Report 2022-h1

Language: English

View Half-year Report
Thumbnail Innate Pharma
 Half-year Report 2021-h1

Half-year Report 2021-h1

Language: English

View Half-year Report
Thumbnail Innate Pharma
 Half-year Report 2021-h1

Half-year Report 2021-h1

Language: French

View Half-year Report
Thumbnail Innate Pharma
 Half-year Report 2020-h1

Half-year Report 2020-h1

Language: French

View Half-year Report